For in vitro diagnostic use. Others OPI2 IVD OPI2 CPS_000190 ONLINE DAT Opiates II 08058113190 OPI2, 700T, cobas c pack green OPI2 07613336121443 Reagents, kits 700 tests cobas c 303/503 true 06334504190 OPI2, 100T, cobas c 701/702 OPI2 04015630930340 Reagents, kits 100 tests cobas c 701/702 true 20767158122 COBAS INTEGRA OPIATES 300/2000 200T OPI2 04015630996094 Reagents, kits 2147653122 200 tests COBAS INTEGRA 400 Plus true 04490894190 OPI2, 200T, cobas c OPI2 04015630997756 Reagents, kits 200 tests cobas c 311/501/502 true 08058113500 OPI2 ONLINE DAT Opiates II en 9 FF00000006F28E0E FF00000004B5E60E 08058113190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useOpiates II (OPI2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of morphine and its metabolites in human urine on cobas c systems at cutoff concentrations of 300 ng/mL and 2000 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS).Opiates II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0208058113190c503 OPI2 ONLINE DAT Opiates II en 6 FF00000006D6950E FF00000005569B0E 08058113190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useOpiates II (OPI2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of morphine and its metabolites in human urine on cobas c systems at cutoff concentrations of 300 ng/mL and 2000 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS).Opiates II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 06334504500 OPI2 ONLINE DAT Opiates II en 8 FF00000006A3EC0E FF0000000061680E 06334504190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useOpiates II (OPI2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of morphine and its metabolites in human urine on cobas c systems at cutoff concentrations of 300 ng/mL and 2000 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Opiates II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0220767158122COIN OPI ONLINE DAT Opiates 300/2000 en 9 FF000000059BFC0E FF000000059BFC0E 20767158122 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useOpiates 300/2000 (OPI) is an in vitro diagnostic test for the semiquantitative and qualitative detection of morphine and its metabolites in human urine at cutoff concentrations of 300 ng/mL and 2000 ng/mL on COBAS INTEGRA systems. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC/MS).Opiates 300/2000 provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0204490894190c501 OPI2 ONLINE DAT Opiates II en 17 FF00000006F2330E FF00000006F2330E 04490894190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useOpiates II (OPI2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of morphine and its metabolites in human urine on cobas c systems at cutoff concentrations of 300 ng/mL and 2000 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS).Opiates II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 04490894500 OPI2 ONLINE DAT Opiates II en 17 FF00000006BEA70E FF0000000073700E 04490894190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useOpiates II (OPI2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of morphine and its metabolites in human urine on cobas c systems at cutoff concentrations of 300 ng/mL and 2000 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS).Opiates II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en